Literature DB >> 18825300

High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.

A Kuwabara1, K Tanaka, N Tsugawa, H Nakase, H Tsuji, K Shide, M Kamao, T Chiba, N Inagaki, T Okano, S Kido.   

Abstract

SUMMARY: Vitamin K and D deficiency and decreased bone mineral density (BMD) were highly prevalent in patients with inflammatory bowel disease (IBD), especially Crohn's disease (CD). Dietary intakes of these vitamins, however, were above the Japanese adequate intakes in IBD patients, suggesting that malabsorption is the basis for hypovitaminosis K and D and decreased BMD.
INTRODUCTION: We have studied the possible involvement of vitamin K and D deficiency in the pathogenesis of decreased BMD in IBD.
METHODS: Seventy patients with IBD were evaluated for their BMD; plasma levels of vitamin K; phylloquinone (PK), menaquinone-7 (MK-7), and 25OH-D; serum PTH, protein induced by vitamin K absence (PIVKA-II), and undercarboxylated osteocalcin (ucOC) levels; and their food intake.
RESULTS: Compared with ulcerative colitis (UC) patients, CD patients had significantly lower plasma vitamin K and 25OH-D concentrations; significantly higher serum levels of PTH, PIVKA-II, and ucOC; and significantly lower BMD scores at almost all measurement sites. More IBD patients were vitamin K deficient in bone than in liver. Multiple regression analyses revealed that low plasma concentrations of vitamin K and 25OH-D were independent risk factors for low BMD and that they were associated with the patients' fat intake, but not with their intake of these vitamins.
CONCLUSION: IBD patients have high prevalence of decreased BMD and vitamin K and D deficiency probably caused by malabsorption of these vitamins.

Entities:  

Mesh:

Year:  2008        PMID: 18825300     DOI: 10.1007/s00198-008-0764-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  41 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 2.  Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.

Authors:  Sarah Cockayne; Joy Adamson; Susan Lanham-New; Martin J Shearer; Simon Gilbody; David J Torgerson
Journal:  Arch Intern Med       Date:  2006-06-26

3.  Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?

Authors:  E J Schoon; M C Müller; C Vermeer; L J Schurgers; R J Brummer; R W Stockbrügger
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  A four-year longitudinal study of bone loss in patients with inflammatory bowel disease.

Authors:  R J Motley; D Clements; W D Evans; E O Crawley; C Evans; J Rhodes; J E Compston
Journal:  Bone Miner       Date:  1993-11

6.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Authors:  S Ardizzone; S Bollani; P Bettica; M Bevilacqua; P Molteni; G Bianchi Porro
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

Review 7.  Effects of vitamin K on bone mass and bone metabolism.

Authors:  C Vermeer; B L Gijsbers; A M Crāciun; M M Groenen-van Dooren; M H Knapen
Journal:  J Nutr       Date:  1996-04       Impact factor: 4.798

8.  Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.

Authors:  Charles N Bernstein; Savita Bector; William D Leslie
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

9.  Vitamin K intake and hip fractures in women: a prospective study.

Authors:  D Feskanich; P Weber; W C Willett; H Rockett; S L Booth; G A Colditz
Journal:  Am J Clin Nutr       Date:  1999-01       Impact factor: 7.045

10.  Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.

Authors:  Leon J Schurgers; Kirsten J F Teunissen; Karly Hamulyák; Marjo H J Knapen; Hogne Vik; Cees Vermeer
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

View more
  31 in total

1.  Urinary levels of cross-linked N-terminal telopeptide of type I collagen and nutritional status in Japanese professional baseball players.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Kazuhiro Uenishi; Hiromi Ishida; Yoshihiro Sato; Hideo Matsumoto
Journal:  J Bone Miner Metab       Date:  2010-02-18       Impact factor: 2.626

Review 2.  Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-18       Impact factor: 4.052

Review 3.  Role of vitamins in gastrointestinal diseases.

Authors:  Omar A Masri; Jean M Chalhoub; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

4.  Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis.

Authors:  Eri Shiraishi; Hideki Iijima; Shinichiro Shinzaki; Sachiko Nakajima; Takahiro Inoue; Satoshi Hiyama; Shoichiro Kawai; Manabu Araki; Toshio Yamaguchi; Yoshito Hayashi; Hironobu Fujii; Tsutomu Nishida; Masahiko Tsujii; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2015-08-28       Impact factor: 7.527

Review 5.  Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

Authors:  Maria Fusaro; Maurizio Gallieni; Camillo Porta; Thomas L Nickolas; Pascale Khairallah
Journal:  J Nephrol       Date:  2019-12-19       Impact factor: 3.902

6.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

7.  Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.

Authors:  Bincy P Abraham; Preethi Prasad; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

Review 8.  Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease.

Authors:  Afif Yaccob; Amir Mari
Journal:  Frontline Gastroenterol       Date:  2018-10-09

9.  Clinical utility of vitamin d testing: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-02-01

Review 10.  Review article: vitamin D and inflammatory bowel diseases.

Authors:  V P Mouli; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.